Humain VenturesCo-founder and General Partner
Until Present
Early-stage fund investing at the intersection of AI and biology: therapeutics, prevention and human health.
Linea Avey is co-founder and General Partner of Humain Ventures, an Austin firm that backs founders building the future of therapeutics, prevention and human health. She co-founded 23andMe in 2006 and served as co-president until 2009, staying on its board until 2011. She sits on the Board of Fellows at Stanford School of Medicine, was on the founding board of Rock Health, is a director of the Human Immunome Project and advises Verily Life Sciences and Colossal Biosciences. With Aneil Mallavarapu she co-founded The Lifespan Project, which explores a prevention-first healthcare system built on lifelong health accounts.
Linea Avey is co-founder and General Partner of Humain Ventures, an Austin firm that backs founders building the future of therapeutics, prevention and human health. She co-founded 23andMe in 2006 and served as co-president until 2009, staying on its board until 2011. She sits on the Board of Fellows at Stanford School of Medicine, was on the founding board of Rock Health, is a director of the Human Immunome Project and advises Verily Life Sciences and Colossal Biosciences. With Aneil Mallavarapu she co-founded The Lifespan Project, which explores a prevention-first healthcare system built on lifelong health accounts.
Career
23andMeCo-founder and Co-president
Mar 2006 — Aug 2009